Jagotamoy Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jagotamoy Das has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
- Shana Olwyn Kelley
Northwestern University, Chan Zuckerberg Biohub, USA
40 shared publications - Edward Hartley Sargent
Department of electrical and computer engineering, University of Toronto, Toronto, Ontario, M5S 3G4, Canada
15 shared publications - Haesik Yang
Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan, Korea
12 shared publications Edward H. Sargent
Department of Chemistry, Weinberg College of Arts & Sciences, Northwestern University, Evanston, USA
10 shared publicationsConnor D. Flynn
Department of Chemistry, Weinberg College of Arts & Sciences, Northwestern University, Evanston, IL, USA
8 shared publicationsHanie Yousefi
Department of Biomedical Engineering, McCormick School of Engineering
8 shared publications
Latest Publications
- 9 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (9) , 8010-8018
Structure-Switching Aptamer-Based Molecular Pendulum for Profiling Melatonin Circadian Dynamics in Humans
Continuous electrochemical monitoring of small molecules remains difficult due to their small size and lack of enzymatic sensing strategies. Here, we develop a structure-switching aptamer molecular pendulum platform for reagentless electrochemical detection of small molecules, including melatonin and cortisol. Target binding induces a conformational change in the receptor, which increases the hydrodynamic diameter of the construct, thereby slowing electron transfer kinetics and resulting in a measurable time-resolved electrochemical current. To explore the feasibility of melatonin sensing in vivo, we validated the presence and circadian dynamics of melatonin in human interstitial fluid using mass spectrometry. We then demonstrated quantitative electrochemical detection of melatonin directly in human ISF, with signals that mirror the circadian profile observed by mass spectrometry. This work provides a foundation for continuous, minimally invasive monitoring of circadian biomarkers using electrochemical sensors.
- 9 September 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (9) , 8010-8018
Structure-Switching Aptamer-Based Molecular Pendulum for Profiling Melatonin Circadian Dynamics in Humans
Continuous electrochemical monitoring of small molecules remains difficult due to their small size and lack of enzymatic sensing strategies. Here, we develop a structure-switching aptamer molecular pendulum platform for reagentless electrochemical detection of small molecules, including melatonin and cortisol. Target binding induces a conformational change in the receptor, which increases the hydrodynamic diameter of the construct, thereby slowing electron transfer kinetics and resulting in a measurable time-resolved electrochemical current. To explore the feasibility of melatonin sensing in vivo, we validated the presence and circadian dynamics of melatonin in human interstitial fluid using mass spectrometry. We then demonstrated quantitative electrochemical detection of melatonin directly in human ISF, with signals that mirror the circadian profile observed by mass spectrometry. This work provides a foundation for continuous, minimally invasive monitoring of circadian biomarkers using electrochemical sensors.
- 10 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (24) , 24597-24602
Integrating Transcription Factors with Electrochemical Pendulum Bioanalysis for Hormone Detection
A challenge for direct biosensing of small molecule biomarkers is transducing the binding of low-molecular weight targets with large affinity receptors into measurable signals. Molecular pendulum bioanalysis enables highly sensitive detection but necessitates that target binding induces a significant change in hydrodynamic radius of the sensor construct. Herein, we demonstrate that receptors with allosteric binding properties can be integrated with molecular pendulum sensors to enable electrochemical detection of steroid hormone analytes. Transcription factors are immobilized on gold electrodes via DNA linkers, forming monolayers that transduce binding events into measurable current changes upon application of a positive voltage. In the presence of the target, allosteric dissociation of the receptor from the linker induces a faster faradaic current response. Using this approach, we employ a steroid-responsive transcription factor to achieve progesterone detection in simulated biofluids and spiked biological samples with relevant sensitivity. Our work establishes a framework for integrating transcription factors as recognition elements for direct electrochemical biosensors, expanding their compatibility to a broader range of analytes.
- 10 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (24) , 24597-24602
Integrating Transcription Factors with Electrochemical Pendulum Bioanalysis for Hormone Detection
A challenge for direct biosensing of small molecule biomarkers is transducing the binding of low-molecular weight targets with large affinity receptors into measurable signals. Molecular pendulum bioanalysis enables highly sensitive detection but necessitates that target binding induces a significant change in hydrodynamic radius of the sensor construct. Herein, we demonstrate that receptors with allosteric binding properties can be integrated with molecular pendulum sensors to enable electrochemical detection of steroid hormone analytes. Transcription factors are immobilized on gold electrodes via DNA linkers, forming monolayers that transduce binding events into measurable current changes upon application of a positive voltage. In the presence of the target, allosteric dissociation of the receptor from the linker induces a faster faradaic current response. Using this approach, we employ a steroid-responsive transcription factor to achieve progesterone detection in simulated biofluids and spiked biological samples with relevant sensitivity. Our work establishes a framework for integrating transcription factors as recognition elements for direct electrochemical biosensors, expanding their compatibility to a broader range of analytes.
- Top Cited PapersOpen Access
- 13 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Biomolecular Condensates as Protein Degradation Tools for Intracellular Targets
Targeted protein degradation harnesses endogenous cellular machinery to eliminate disease-causing proteins, yet achieving phenotype-specific degradation across diverse cell types remains challenging. Here we show that antibody-enriched biomolecular condensates formed by liquid-liquid phase separation function as intracellular protein degradation tools, combining cytosolic trafficking with direct proteasome recruitment for targeted substrate clearance. These nanoscale condensates incorporate a short proteasome-targeting motif into phase-separation precursors, preserve antibody activity, enable direct proteasome recruitment, and improve delivery uniformity. When loaded with a mutation-specific antibody, these condensates selectively degrade oncogenic KRAS G12V without affecting wild-type KRAS in heterozygous cells, and suppress tumor growth in a KRAS G12V xenograft model. This strategy provides a modular platform for intracellular protein degradation that can be readily adapted by exchanging antibodies, without requiring genetic modification of cellular system.
- 13 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Top Cited PapersOpen AccessBiomolecular Condensates as Protein Degradation Tools for Intracellular Targets
Targeted protein degradation harnesses endogenous cellular machinery to eliminate disease-causing proteins, yet achieving phenotype-specific degradation across diverse cell types remains challenging. Here we show that antibody-enriched biomolecular condensates formed by liquid-liquid phase separation function as intracellular protein degradation tools, combining cytosolic trafficking with direct proteasome recruitment for targeted substrate clearance. These nanoscale condensates incorporate a short proteasome-targeting motif into phase-separation precursors, preserve antibody activity, enable direct proteasome recruitment, and improve delivery uniformity. When loaded with a mutation-specific antibody, these condensates selectively degrade oncogenic KRAS G12V without affecting wild-type KRAS in heterozygous cells, and suppress tumor growth in a KRAS G12V xenograft model. This strategy provides a modular platform for intracellular protein degradation that can be readily adapted by exchanging antibodies, without requiring genetic modification of cellular system.
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- 30 March 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (13) , 18702-18720
MXene–Quantum Dot Heterostructures in the Water–Energy Nexus: Simultaneous Photocatalytic Pollutant Degradation and Electrochemical Energy Storage
The challenges of the global water shortage and increasing energy consumption are related problems that need to be addressed by creative solutions. This urges the development of multifunctional materials capable of combining water purification and sustainable energy recovery. MXene-quantum dot heterostructures have recently emerged as an outstanding dual-functional platform, which integrates the high electrical conductivity, hydrophilicity, and flexible surface chemistry of MXenes with the tunable optoelectronic features of quantum dots. Since their discovery in 2011, MXenes have garnered significant interest for energy storage due to their metallic conductivity (reaching 15,000 S/cm) and layered structures, driving modification strategies such as double-transition metal integration and heteroatom doping to overcome challenges like layer restacking and enhance capacitance up to 520 F/g. Concurrently, next-generation biosensors leverage advanced platforms including hexagonal boron nitride, covalent triazine frameworks, and surface-engineered M5X4 MXenes to achieve detection limits as low as 10 pM and sensitivities reaching 0.1 ppb through enhanced conductivity and multimodal detection capabilities. In this review, we discuss the synergistic construction of the MXene-quantum dots interface for dual functional purposes of both photocatalytic degradation of pollutants and electrochemical energy storage. While the distinctive 0D/2D and 2D/2D architectures enable high-speed charge transfer for depletion of surface charges as well as recombination suppression, the tailored surface terminations promote ion diffusion and pollutant capture. These heterostructures exhibit high efficiency in reactive oxygen species generation and can lead to the degradation of organic dye, heavy metals, and recalcitrant micropollutants, such as per- and polyfluoroalkyl substances (PFASs) and pharmaceuticals. Simultaneously, the addition of quantum dots brings pseudo capacitive characteristics and band gap engineering to supercapacitors, exhibiting high areal capacitances (>5 F cm-2) and Coulombic efficiencies >98%. Rigorous electronic coupling and long-lived charge separation are validated by operando Raman and femtosecond transient-absorption spectroscopy, which support the Z-scheme charge transfer processes driving dual-functionality. Such demonstrations of concepts, as flow-through photosupercapacitors, show that recovery of energy during solar-driven wastewater treatment is feasible. Although hurdles in material manufacturability and stability remain, progress in roll-to-roll production and AI-supported discovery should fast-track industrial uptake. Ultimately, the goal is to transition from proof-of-concept devices, like photorechargeable supercapacitors, to integrated, solar-powered systems that treat wastewater while offsetting their own energy consumption. Further, we discuss the future progress hinges on defect engineering at the interface, scalable fabrication of 3D macrostructures, and address the inherent stability challenges of both MXenes and quantum dots in aqueous environments.
- 30 March 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (13) , 18702-18720
MXene–Quantum Dot Heterostructures in the Water–Energy Nexus: Simultaneous Photocatalytic Pollutant Degradation and Electrochemical Energy Storage
The challenges of the global water shortage and increasing energy consumption are related problems that need to be addressed by creative solutions. This urges the development of multifunctional materials capable of combining water purification and sustainable energy recovery. MXene-quantum dot heterostructures have recently emerged as an outstanding dual-functional platform, which integrates the high electrical conductivity, hydrophilicity, and flexible surface chemistry of MXenes with the tunable optoelectronic features of quantum dots. Since their discovery in 2011, MXenes have garnered significant interest for energy storage due to their metallic conductivity (reaching 15,000 S/cm) and layered structures, driving modification strategies such as double-transition metal integration and heteroatom doping to overcome challenges like layer restacking and enhance capacitance up to 520 F/g. Concurrently, next-generation biosensors leverage advanced platforms including hexagonal boron nitride, covalent triazine frameworks, and surface-engineered M5X4 MXenes to achieve detection limits as low as 10 pM and sensitivities reaching 0.1 ppb through enhanced conductivity and multimodal detection capabilities. In this review, we discuss the synergistic construction of the MXene-quantum dots interface for dual functional purposes of both photocatalytic degradation of pollutants and electrochemical energy storage. While the distinctive 0D/2D and 2D/2D architectures enable high-speed charge transfer for depletion of surface charges as well as recombination suppression, the tailored surface terminations promote ion diffusion and pollutant capture. These heterostructures exhibit high efficiency in reactive oxygen species generation and can lead to the degradation of organic dye, heavy metals, and recalcitrant micropollutants, such as per- and polyfluoroalkyl substances (PFASs) and pharmaceuticals. Simultaneously, the addition of quantum dots brings pseudo capacitive characteristics and band gap engineering to supercapacitors, exhibiting high areal capacitances (>5 F cm-2) and Coulombic efficiencies >98%. Rigorous electronic coupling and long-lived charge separation are validated by operando Raman and femtosecond transient-absorption spectroscopy, which support the Z-scheme charge transfer processes driving dual-functionality. Such demonstrations of concepts, as flow-through photosupercapacitors, show that recovery of energy during solar-driven wastewater treatment is feasible. Although hurdles in material manufacturability and stability remain, progress in roll-to-roll production and AI-supported discovery should fast-track industrial uptake. Ultimately, the goal is to transition from proof-of-concept devices, like photorechargeable supercapacitors, to integrated, solar-powered systems that treat wastewater while offsetting their own energy consumption. Further, we discuss the future progress hinges on defect engineering at the interface, scalable fabrication of 3D macrostructures, and address the inherent stability challenges of both MXenes and quantum dots in aqueous environments.
- 7 November 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (22) , 3379-3391
Toward Reagentless and Universal Biomolecular Sensing: Molecular Pendulum-Based Bioanalysis
ConspectusContinuous monitoring of physiologically relevant analytes remains an unmet need of high interest to the medical community. Complex biological environments, slow-release affinity receptors, and short sensor lifetimes are just some of the many challenges that stand in the way of delivering real-time analysis for disease diagnosis, prevention, and treatment. Electrochemical biomolecular sensors are poised to address many of these challenges, given their demonstrated ability to detect a wide range of analytes, from proteins to small molecules, in various in vivo applications. Our laboratory has a strong interest in developing electrochemical biomolecular sensors for long-term continuous health monitoring with the ultimate goal of achieving a universal sensing platform.In this Account, we summarize our group's efforts to develop a universal, reagentless continuous monitoring platform for a multitude of biologically relevant targets. We first introduced the molecular pendulum (MP) sensing approach in 2021, which enabled the detection of a variety of essential protein analytes in their physiologically relevant ranges. In subsequent work, we have addressed some limitations to MP universality, first by expanding the analyte scope to include viral particles and electroactive small molecules. We further demonstrated that the MP platform could be integrated with a variety of target receptors, including antibodies, nanobodies, and aptamers, further expanding the receptor space and analyte range of this platform. To address one of the most significant challenges facing the biomolecular sensing community─the inability to overcome strong receptor binding and continuously monitor analytes─we developed an active-reset method for the MP, enabling the continuous detection of proteins through oscillatory receptor regeneration. To integrate sensors into bioelectronic interfaces, we have demonstrated MP function in various microneedle platforms capable of interstitial fluid sampling and monitoring. This platform enabled our laboratory to begin performing a wide range of in vivo tests, as we look forward to new implantable and wearable form factors. Combining all the above factors, we have started to utilize our MP sensing systems to gain critical insights into physiological mechanisms such as inflammation and circadian rhythm disruption by monitoring molecular fluctuations. Given the success of the MP system in targeting a large variety of analytes with high sensitivity, receptor modularity, and in vivo compatibility, we believe that MP sensing can be expanded further and has high potential to serve as a model for universal biomolecular sensing.
- 7 November 2025
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 58 (22) , 3379-3391
Toward Reagentless and Universal Biomolecular Sensing: Molecular Pendulum-Based Bioanalysis
ConspectusContinuous monitoring of physiologically relevant analytes remains an unmet need of high interest to the medical community. Complex biological environments, slow-release affinity receptors, and short sensor lifetimes are just some of the many challenges that stand in the way of delivering real-time analysis for disease diagnosis, prevention, and treatment. Electrochemical biomolecular sensors are poised to address many of these challenges, given their demonstrated ability to detect a wide range of analytes, from proteins to small molecules, in various in vivo applications. Our laboratory has a strong interest in developing electrochemical biomolecular sensors for long-term continuous health monitoring with the ultimate goal of achieving a universal sensing platform.In this Account, we summarize our group's efforts to develop a universal, reagentless continuous monitoring platform for a multitude of biologically relevant targets. We first introduced the molecular pendulum (MP) sensing approach in 2021, which enabled the detection of a variety of essential protein analytes in their physiologically relevant ranges. In subsequent work, we have addressed some limitations to MP universality, first by expanding the analyte scope to include viral particles and electroactive small molecules. We further demonstrated that the MP platform could be integrated with a variety of target receptors, including antibodies, nanobodies, and aptamers, further expanding the receptor space and analyte range of this platform. To address one of the most significant challenges facing the biomolecular sensing community─the inability to overcome strong receptor binding and continuously monitor analytes─we developed an active-reset method for the MP, enabling the continuous detection of proteins through oscillatory receptor regeneration. To integrate sensors into bioelectronic interfaces, we have demonstrated MP function in various microneedle platforms capable of interstitial fluid sampling and monitoring. This platform enabled our laboratory to begin performing a wide range of in vivo tests, as we look forward to new implantable and wearable form factors. Combining all the above factors, we have started to utilize our MP sensing systems to gain critical insights into physiological mechanisms such as inflammation and circadian rhythm disruption by monitoring molecular fluctuations. Given the success of the MP system in targeting a large variety of analytes with high sensitivity, receptor modularity, and in vivo compatibility, we believe that MP sensing can be expanded further and has high potential to serve as a model for universal biomolecular sensing.
- 16 September 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (9) , 7051-7059
Dual-Chronoamperometry Drift Correction for Electrochemical Sensors
Accurate sensing of biomolecular targets is crucial for diagnosing diseases and developing technologies for personalized medicine. However, measuring biomarker levels with high precision is often challenging due to signal drift caused by biofouling and monolayer instability. We demonstrate a novel continuous dual-chronoamperometry method with faradaic current extraction to enable accurate and reliable detection of biomarkers in the presence of drift. We apply two sequential chronoamperometry pulses, a reference (-500 mV) and a test (+500 mV), to capture all capacitive and faradaic currents in the range. In the absence of the target, the drift in the reference and test currents is multilinear, and this relationship can be used to predict the contribution of the target current. As a proof-of-concept, we demonstrate that signal drift can be corrected using our molecular pendulum for IFN-γ detection. Importantly, we show that this technique is broadly applicable to other amperometry-based systems such as a monolayer transporter sensor, an electrochemical DNA sensor, and electrochemical aptamer-based sensors. Moreover, we train a linear regression machine learning model and use its error to quantify target concentrations with dual-chronoamperometry data. This novel method enhances the reliability and sensitivity of chronoamperometry, paving the way for its application in real-time monitoring scenarios.
- 16 September 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (9) , 7051-7059
Dual-Chronoamperometry Drift Correction for Electrochemical Sensors
Accurate sensing of biomolecular targets is crucial for diagnosing diseases and developing technologies for personalized medicine. However, measuring biomarker levels with high precision is often challenging due to signal drift caused by biofouling and monolayer instability. We demonstrate a novel continuous dual-chronoamperometry method with faradaic current extraction to enable accurate and reliable detection of biomarkers in the presence of drift. We apply two sequential chronoamperometry pulses, a reference (-500 mV) and a test (+500 mV), to capture all capacitive and faradaic currents in the range. In the absence of the target, the drift in the reference and test currents is multilinear, and this relationship can be used to predict the contribution of the target current. As a proof-of-concept, we demonstrate that signal drift can be corrected using our molecular pendulum for IFN-γ detection. Importantly, we show that this technique is broadly applicable to other amperometry-based systems such as a monolayer transporter sensor, an electrochemical DNA sensor, and electrochemical aptamer-based sensors. Moreover, we train a linear regression machine learning model and use its error to quantify target concentrations with dual-chronoamperometry data. This novel method enhances the reliability and sensitivity of chronoamperometry, paving the way for its application in real-time monitoring scenarios.
- 7 August 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 10 (3) , 445-457
Continuous insulin monitoring using an antibody-protecting zwitterionic microneedle patch
Continuous monitoring of protein and molecular biomarkers is essential for personalized disease tracking, but approaches for in vivo sensing are limited. Monitoring insulin, a peptide hormone, is an unmet need given the importance of this molecule in managing diabetes. Here we report a patch-based system with integrated electrochemical sensors that enables monitoring of insulin levels on an ongoing basis. We report a novel zwitterionic-based hydrogel microneedle patch with integrated molecular pendulum sensors that can measure insulin levels in the interstitial fluid of rats with type 1 diabetes. Our study demonstrates that the zwitterionic poly(carboxybetaine)-based microneedle patch stabilizes the antibody-based recognition elements, allowing them to withstand UV-induced crosslinking during patch fabrication and gamma-irradiation, often required for FDA-standard sterilization. We also investigate the impact of disrupted circadian rhythm on insulin levels, revealing circadian-dependent alterations in insulin absorption efficiency and distribution within the interstitial fluid and plasma. This platform not only enhances our understanding of in vivo insulin behaviour but also holds promise for personalized treatment strategies in diabetes management.
- 7 August 2025
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 10 (3) , 445-457
Continuous insulin monitoring using an antibody-protecting zwitterionic microneedle patch
Continuous monitoring of protein and molecular biomarkers is essential for personalized disease tracking, but approaches for in vivo sensing are limited. Monitoring insulin, a peptide hormone, is an unmet need given the importance of this molecule in managing diabetes. Here we report a patch-based system with integrated electrochemical sensors that enables monitoring of insulin levels on an ongoing basis. We report a novel zwitterionic-based hydrogel microneedle patch with integrated molecular pendulum sensors that can measure insulin levels in the interstitial fluid of rats with type 1 diabetes. Our study demonstrates that the zwitterionic poly(carboxybetaine)-based microneedle patch stabilizes the antibody-based recognition elements, allowing them to withstand UV-induced crosslinking during patch fabrication and gamma-irradiation, often required for FDA-standard sterilization. We also investigate the impact of disrupted circadian rhythm on insulin levels, revealing circadian-dependent alterations in insulin absorption efficiency and distribution within the interstitial fluid and plasma. This platform not only enhances our understanding of in vivo insulin behaviour but also holds promise for personalized treatment strategies in diabetes management.
- 2 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (14) , 7825-7832
Nanobody Receptors Enable High-Sensitivity Monitoring of IL-6 Using Molecular Pendulum Bioanalysis
The development of biomolecular sensing technologies with high sensitivity and specificity remains an important goal in modern analytical science. Molecular pendulum sensing has emerged as a new reagentless method capable of detecting a wide array of biomolecules directly in biological fluids. This sensing approach relies heavily on the modulation of hydrodynamic drag of molecular probes through solution, such that alterations in hydrodynamic diameter can transduce biomolecular interactions. Here, we explore the use of nanobodies as an alternative receptor in pendulum-based systems due to their small size and robust affinities. We compare the performance of nanobodies with that of aptamers and antibodies integrated into the molecular pendulum system by targeting the inflammatory indicator interleukin-6 (IL-6). Nanobody molecular pendulums demonstrate enhanced sensor response and sensitivity compared to those of the other receptors, enabling fine control over detection in the low physiological range of IL-6. In addition, we demonstrate the ability of nanobody sensors to function in complex biological matrices and at physiological temperature.
- 2 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (14) , 7825-7832
Nanobody Receptors Enable High-Sensitivity Monitoring of IL-6 Using Molecular Pendulum Bioanalysis
The development of biomolecular sensing technologies with high sensitivity and specificity remains an important goal in modern analytical science. Molecular pendulum sensing has emerged as a new reagentless method capable of detecting a wide array of biomolecules directly in biological fluids. This sensing approach relies heavily on the modulation of hydrodynamic drag of molecular probes through solution, such that alterations in hydrodynamic diameter can transduce biomolecular interactions. Here, we explore the use of nanobodies as an alternative receptor in pendulum-based systems due to their small size and robust affinities. We compare the performance of nanobodies with that of aptamers and antibodies integrated into the molecular pendulum system by targeting the inflammatory indicator interleukin-6 (IL-6). Nanobody molecular pendulums demonstrate enhanced sensor response and sensitivity compared to those of the other receptors, enabling fine control over detection in the low physiological range of IL-6. In addition, we demonstrate the ability of nanobody sensors to function in complex biological matrices and at physiological temperature.
- 24 February 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (9) , 7868-7874
Antifouling Spiky Nanoelectrodes Enhance Detection of Bacterial mRNA
Nanomaterials have extensive applications in the development of sensitive biosensors, but the influence of their specific structural properties remains unclear. This work presents a platform that can provide mechanistic insight into how nanostructured electrodes improve the performance of electrochemical biosensors. We designed nanoelectrodes with sub-10 nm spike features through a combination of top-down lithography and solution-based synthesis. These anisotropic structures facilitated rapid electron-transfer, minimized biofouling, and promoted efficient target capture. Using these spiky nanoelectrodes in a biosensor, we detected bacterial mRNA at aM-levels and within 3 min. Our findings reveal the mechanism underlying signal enhancement from high-curvature regions on nanostructured electrodes, highlighting the structure-property relationships of nanostructures in electrochemical sensing.
- 24 February 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (9) , 7868-7874
Antifouling Spiky Nanoelectrodes Enhance Detection of Bacterial mRNA
Nanomaterials have extensive applications in the development of sensitive biosensors, but the influence of their specific structural properties remains unclear. This work presents a platform that can provide mechanistic insight into how nanostructured electrodes improve the performance of electrochemical biosensors. We designed nanoelectrodes with sub-10 nm spike features through a combination of top-down lithography and solution-based synthesis. These anisotropic structures facilitated rapid electron-transfer, minimized biofouling, and promoted efficient target capture. Using these spiky nanoelectrodes in a biosensor, we detected bacterial mRNA at aM-levels and within 3 min. Our findings reveal the mechanism underlying signal enhancement from high-curvature regions on nanostructured electrodes, highlighting the structure-property relationships of nanostructures in electrochemical sensing.